[ESPR] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
27-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 9.41%
YoY- -3.18%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 3,833 212,236 1,840 982 981 982 145,419 -91.08%
PBT -85,437 124,611 -78,249 -61,946 -68,377 -54,221 87,379 -
Tax 4,970 4,721 4,539 5,165 5,383 0 0 -
NP -85,437 124,611 -78,249 -61,946 -68,377 -54,221 87,379 -
Tax Rate - -3.79% - - - - 0.00% -
Total Cost 89,270 87,625 80,089 62,928 69,358 55,203 58,040 33.14%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -2,228.99 58.71 -4,252.66 -6,308.15 -6,970.13 -5,521.49 60.09 -
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -3.07 4.50 -2.84 -2.26 -2.52 -2.01 3.26 -
EPS Diluted -3.07 4.32 -2.84 -2.26 -2.52 -2.01 3.07 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.